Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs505922
rs505922
ABO
C 0.740 GeneticVariation GWASCAT Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. 29422604

2018

dbSNP: rs505922
rs505922
ABO
0.740 GeneticVariation GWASCAT Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 26098869

2015

dbSNP: rs505922
rs505922
ABO
0.740 GeneticVariation BEFREE This study provided evidence of SNP rs505922 C allele as a strong risk factor of cancer susceptibility, specifically for pancreatic cancer. 25656610

2015

dbSNP: rs505922
rs505922
ABO
0.740 GeneticVariation BEFREE SNP rs505922, located within the first intron of the ABO gene, has been associated with the adenocarcinoma subtype of pancreatic cancer. 22642827

2012

dbSNP: rs505922
rs505922
ABO
0.740 GeneticVariation BEFREE Consistent with earlier reports showing a higher risk of PC for individuals with the non-O blood type, the previously reported protective allele (T) for rs505922 was found to be strongly correlated (r(2) = 0.96) with the O allele. 21306478

2011

dbSNP: rs505922
rs505922
ABO
C 0.740 GeneticVariation GWASCAT We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28). 19648918

2009

dbSNP: rs505922
rs505922
ABO
0.740 GeneticVariation BEFREE We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28). 19648918

2009